These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 29432302
1. Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine. Takpradit C, Prockop SE, Kernan NA, Scaradavou A, Curran K, Ruggiero J, Zakak N, O'Reilly RJ, Boulad F. J Pediatr Hematol Oncol; 2018 May; 40(4):e220-e224. PubMed ID: 29432302 [Abstract] [Full Text] [Related]
2. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan. Chaudhry QUN, Iftikhar R, Satti TM, Mahmood SK, Ghafoor T, Shamshad GU, Farhan M, Shahbaz N, Khan MA, Khattak TA, Rehman J, Humayun S, Satti HS, Anwer F, Ahmed P. Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274 [Abstract] [Full Text] [Related]
4. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies. Kang HJ, Hong KT, Lee JW, Kim H, Park KD, Shin HY, Lee SH, Yoo KH, Sung KW, Koo HH, Lee JW, Chung NG, Cho B, Kim HK, Koh KN, Im HJ, Seo JJ, Jung HJ, Park JE, Lee YH, Lim YT, Lim YJ, Kim SY, Yoo ES, Ryu KH, Lee JH, Park JA, Park SK, Ahn HS, Korean Society of Pediatric Hematology-Oncology. Biol Blood Marrow Transplant; 2016 Aug; 22(8):1455-1459. PubMed ID: 27090956 [Abstract] [Full Text] [Related]
5. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Kim H, Lee JH, Joo YD, Bae SH, Hyun MS, Lee JH, Kim DY, Lee WS, Ryoo HM, Kim MK, Park JH, Lee KH, Cooperative Study Group A for Hematology (COSAH). Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363 [Abstract] [Full Text] [Related]
6. Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemia. Ben Abdeljelil N, Ben Yaiche I, Ouerghi R, Torjemane L, Belloumi D, Turki I, Mekni S, Kanoun RY, Ben Othman T, Ladeb S. Expert Rev Hematol; 2024 Aug; 17(8):527-538. PubMed ID: 39011776 [Abstract] [Full Text] [Related]
7. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Kang HJ, Shin HY, Choi HS, Ahn HS. Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866 [Abstract] [Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, Kobayashi T, Kato J, Yano S, Shimizu H, Shono K, Tanaka M, Tsukamoto S, Mori T, Yamazaki E, Najima Y, Hangaishi A, Hoshino T, Watanabe R, Matsumoto K, Okamoto S, for Kanto Study Group for Cell Therapy (KSGCT). Am J Hematol; 2020 Mar; 95(3):251-257. PubMed ID: 31804748 [Abstract] [Full Text] [Related]
9. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS, Kwak DH, Jeon YW, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Lee JW. Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [Abstract] [Full Text] [Related]
10. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Deeg HJ, Amylon ID, Harris RE, Collins R, Beatty PG, Feig S, Ramsay N, Territo M, Khan SP, Pamphilon D, Leis JF, Burdach S, Anasetti C, Hackman R, Storer B, Mueller B. Biol Blood Marrow Transplant; 2001 Sep; 7(4):208-15. PubMed ID: 11349807 [Abstract] [Full Text] [Related]
11. Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG. Kim H, Lee KH, Kim I, Sohn SK, Jung CW, Joo YD, Kim SH, Kim BS, Choi JH, Kwak JY, Kim MK, Bae SH, Shin HJ, Won JH, Lee WS, Oh S, Kim HJ, Park JH, Korean Society of Blood and Marrow Transplantation. Leuk Res; 2014 Jul; 38(7):730-6. PubMed ID: 24840870 [Abstract] [Full Text] [Related]
12. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Saldaña BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M. Blood Adv; 2019 Oct 22; 3(20):3123-3131. PubMed ID: 31648332 [Abstract] [Full Text] [Related]
13. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR. Bone Marrow Transplant; 2001 Oct 22; 28(7):643-7. PubMed ID: 11704786 [Abstract] [Full Text] [Related]
14. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L. Biol Blood Marrow Transplant; 2003 Jul 22; 9(7):453-9. PubMed ID: 12869959 [Abstract] [Full Text] [Related]
15. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N, Sawada H, Hanada M, Shibata T, Tabata N, Watanabe M, Shimono Y, Deguchi T, Umemoto M, Higashikawa M, Kawasaki H, Komada Y, Sakurai M. Bone Marrow Transplant; 1997 Jun 22; 19(11):1085-7. PubMed ID: 9193750 [Abstract] [Full Text] [Related]
16. An Antithymocyte Globulin-Free Conditioning Regimen Using Fludarabine and Cyclophosphamide Is Associated with Good Outcomes in Patients Undergoing Matched Related Family Donor Transplantation for Aplastic Anemia. George B, Lionel S, Selvarajan S, Abubacker FN, Korula A, Devasia AJ, Kulkarni U, Lakshmi KM, Sindhuvi E, Abraham A, Mathews V. Transplant Cell Ther; 2021 May 22; 27(5):409.e1-409.e6. PubMed ID: 33965181 [Abstract] [Full Text] [Related]
17. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. Ayas M, Al-Seraihi A, El-Solh H, Al-Ahmari A, Khairy A, Aldali A, Markiz S, Siddiqui K, Al-Jefri A. Biol Blood Marrow Transplant; 2012 Apr 22; 18(4):627-32. PubMed ID: 21871862 [Abstract] [Full Text] [Related]